30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

888 PHARMACEUTICAL PREFORMULATION<br />

TABLE 3<br />

Granulating Agent<br />

Starch<br />

Pregelatinized starch<br />

Acacia<br />

Commonly Used Granulating (Binding) Agents<br />

Polyvinylpyrrolidone<br />

(PVP)<br />

Hydroxypropyl<br />

methylcellulose (HPMC)<br />

Methylcellulose (MC)<br />

Normal<br />

Concentration<br />

(%)<br />

5 – 25<br />

0.1 – 0.5<br />

1 – 5<br />

2 – 8<br />

2 – 8<br />

1 – 5<br />

Comments<br />

Was once the most commonly used binder;<br />

starch has to be prepared as paste, which<br />

is time consuming<br />

Cold - water soluble so easier to prepare<br />

than starch<br />

Requires preparation of past prior to use;<br />

can lead to prolonged disintegration<br />

times if used at too high a concentration<br />

Available in range of molecular weight/<br />

viscosities; soluble in water <strong>and</strong> ethanol<br />

Low - viscosity grades most widely used<br />

wetting of hydrophobic drugs. However, if added at too great concentrations, the<br />

fi lms can form viscous gels on the granule surface <strong>and</strong> will retard dissolution.<br />

Disintegrant Tablets must have suffi cient strength to withst<strong>and</strong> the stresses of<br />

subsequent manufacturing operations, such as the coating, packaging, <strong>and</strong> distribution<br />

process. However, once the tablet is taken by the patient, it must break up<br />

rapidly to ensure rapid dissolution of the active ingredient in immediate - release<br />

preparations. To overcome the cohesive strength produced by the compression<br />

process <strong>and</strong> to break down the tablet into the primary particles as rapidly as possible,<br />

the disintegrants are combined with other excipients during the tableting process.<br />

Starch was the fi rst disintegrant used in tablet manufacture. Recently, so - called<br />

superdisintegrants, including croscarmellose sodium, sodium starch glycolate, <strong>and</strong><br />

crospovidone, display excellent disintegration activity at low concentrations <strong>and</strong><br />

have better compression properties than starches. Traditionally, swelling <strong>and</strong> rate of<br />

swelling have been regarded as the most important characteristics of disintegrants.<br />

With the aid of these superdisintegrants, sustained - release acetaminophen tablets<br />

with biphasic patterns were successfully established to mimic the bilayered Tylenol<br />

ER tablet [9]. As a general rule, soluble drugs are formulated with insoluble fi llers<br />

to maximize the effect of disintegrants. The positioning of disintegrants within the<br />

intragranular <strong>and</strong> extragranular portions of granulated formulations can affect their<br />

water uptake <strong>and</strong> disintegration time.<br />

Commonly used disintegrants are listed in Table 4 . The greater the level of disintegrant,<br />

the faster the tablet will disintegrate. The compaction properties of many<br />

disintegrants, including starch, are not satisfactory <strong>and</strong> use of high concentration<br />

could also reduce tablet strength. Disintegrants are hygroscopic materials <strong>and</strong> will<br />

absorb moisture from the atmosphere, which could negatively affect the stability of<br />

moisture - sensitive drugs if the packaging does not provide adequate protection<br />

from the environment. Disintegrant activity can be affected by mixing with hydrophobic<br />

lubricants so that care needs to be taken to optimize the manufacturing<br />

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!